Stay updated on Cannabidiol for AUD & PTSD Clinical Trial
Sign up to get notified when there's something new on the Cannabidiol for AUD & PTSD Clinical Trial page.

Latest updates to the Cannabidiol for AUD & PTSD Clinical Trial page
- Check4 days agoChange DetectedAdded a new Locations section listing New York as a study site; removed the older New York Locations header and the HHS Vulnerability Disclosure footer link.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2; there are no changes to study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check39 days agoChange DetectedRemoved the government funding status notice from the page. The rest of the study details and sections remain unchanged.SummaryDifference0.3%

- Check54 days agoChange DetectedBoth screenshots display the same study details for NCT03248167, with no updates to outcomes, enrollment, or status; any differences are limited to formatting/UI elements. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check82 days agoChange DetectedMajor update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing the old v3.1.0.SummaryDifference2%

- Check90 days agoChange DetectedSummary: The page version is upgraded to v3.1.0 and several pharmaceutical categories (Placebos, Therapeutics, Pharmaceutical Preparations) are removed, indicating a scope revision rather than new core content.SummaryDifference0.2%

Stay in the know with updates to Cannabidiol for AUD & PTSD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cannabidiol for AUD & PTSD Clinical Trial page.